| Q46618495 | Agenesis of ductus venosus in sequential first and second trimester screening |
| Q51501850 | Contribution of "modified genetic sonography" to the combined test as a screening method for chromosomal abnormalities. |
| Q36308492 | First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. |
| Q24187589 | First trimester serum tests for Down's syndrome screening |
| Q36308489 | First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening |
| Q36848484 | Noninvasive screening tools for Down syndrome: a review |
| Q60054137 | Prenatal diagnosis and pregnancy outcome analysis of thickened nuchal fold in the second trimester |
| Q37322448 | Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood |
| Q84836506 | Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA |
| Q51376807 | Role of fetal echocardiography in stepwise sequential screening for chromosomal disorders (combined test associated with modified genetic sonography). |
| Q36776424 | Role of second-trimester genetic sonography after Down syndrome screening |
| Q38179321 | Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing |
| Q43424745 | What is the importance of second-trimester "soft markers" for trisomy 21 after an 11- to 14-week aneuploidy screening scan? |